Back to top
more

Canopy Growth (CGC)

(Delayed Data from NSDQ)

$6.21 USD

6.21
1,989,892

+0.07 (1.14%)

Updated Aug 23, 2024 04:00 PM ET

After-Market: $6.20 -0.01 (-0.16%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 39% (99 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Sanghamitra Saha headshot

5 Best Leveraged ETFs of Last Week Up At Least 10%

Wall Street was mixed-to-downbeat last week. A new 40-year high inflation reading and rising rate worries played spoilsport.

Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates

Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of 4.35% and 1.12%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Canopy Growth (CGC) in Q3 Earnings?

New product launches across the CBD product portfolio and robust demand for legal cannabis products are likely to drive Canopy Growth's (CGC) Q3 top line.

Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know

Canopy Growth Corporation (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Canopy Growth Corporation (CGC) closed at $7.40, marking a +1.51% move from the previous day.

Canopy Growth Corporation (CGC) Stock Moves -1.05%: What You Should Know

Canopy Growth Corporation (CGC) closed at $7.56 in the latest trading session, marking a -1.05% move from the prior day.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Canopy Growth Corporation (CGC) closed at $8.40, marking a -0.12% move from the previous day.

Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know

Canopy Growth Corporation (CGC) closed the most recent trading day at $8.21, moving -1.91% from the previous trading session.

Ulta Beauty and Freshpet have been highlighted as Zacks Bull and Bear of the Day

Ulta Beauty and Freshpet have been highlighted as Zacks Bull and Bear of the Day

Tirthankar Chakraborty headshot

Ride The Cannabis Legalization Wave With These 3 Stocks

Stocks like Cronos Group (CRON), Canopy Growth (CGC) and Innovative Industrial Properties (IIPR) are sure to benefit at present amid the cannabis legalization wave.

Do Options Traders Know Something About Canopy Growth (CGC) Stock We Don't?

Investors need to pay close attention to for Canopy Growth (CGC) stock based on the movements in the options market lately.

Canopy Growth Corporation (CGC) Gains But Lags Market: What You Should Know

Canopy Growth Corporation (CGC) closed at $9.27 in the latest trading session, marking a +1.31% move from the prior day.

Neena Mishra headshot

Should You Buy Beaten Down Cannabis Stocks & ETFs Now?

CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates

Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -178.57% and -6.23%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Canopy Growth (CGC) in Q2 Earnings?

Canopy Growth's (CGC) newly-added Ace Valley and Supreme Cannabis hold part of the company's market share in fiscal Q2.

Clover Health (CLOV) to Report Q3 Earnings: What's in Store?

Clover Health's (CLOV) third-quarter results are likely to benefit from Direct Contracting and strategic partnerships.

Canopy Growth Corporation (CGC) Expected to Beat Earnings Estimates: Should You Buy?

Canopy Growth Corporation (CGC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Humana (HUM) to Post Q3 Earnings: What's in the Cards?

Humana's (HUM) third-quarter earnings are expected to have gained from higher revenues and a solid contribution from its Retail and Healthcare Services segments.

Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Canopy Growth Corporation (CGC) closed at $13.01, marking a +1.76% move from the previous day.

Urmimala Biswas headshot

4 Medical Products Stocks Poised to Beat This Earnings Season

Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.

AmerisourceBergen (ABC) to Post Q4 Earnings: What's in Store?

AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.

DENTSPLY SIRONA (XRAY) to Post Q3 Earnings: What's in Store?

DENTSPLY SIRONA (XRAY) third-quarter results are likely to reflect strong segmental performance.

Conformis (CFMS) to Post Q3 Earnings: What's in the Offing?

Conformis' (CFMS) third-quarter results are likely to reflect strength in core products.

PerkinElmer (PKI) to Post Q3 Earnings: What's in the Cards?

PerkinElmer's (PKI) third-quarter results are likely to reflect strong performance at the Diagnostics segment.

McKesson (MCK) to Report Q2 Earnings: What's in the Cards?

McKesson's (MCK) fiscal second-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.